Product Information

NAPROXEN 500 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.0601 per EA under NDC 68462019005. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Mar 28, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

NAPROXEN 500 MG TABLET

Naproxen
$0.0601per EA

Strength

500 mg/1

NDC

68462019005

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

NAPROXEN

Approval Type

Generic (ANDA)

FDA Application

ANDA078250

FDA Approved

3/28/2007

TE Code

AB

On Market Since

7/1/2007

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for NAPROXEN 500 MG TABLET has been published 678 times since Nov 28, 2013, and over the history we have for it it has risen 20.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0601 per EA
All-time high$0.0874 (Aug 12, 2020)
All-time low$0.0497 (Apr 17, 2024)
52-week high$0.0654
52-week low$0.0565
Median price$0.0660
Average price$0.0664
Largest weekly change+33.6% (Jun 19, 2024)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

+3.9%

1M

+6.3%

3M

+3.6%

6M

-3.9%

1Y

-6.7%

3Y

-5.6%

5Y

-21.5%

All

+20.9%

Generic Alternatives

The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of NAPROXEN 500 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for NAPROXEN 500 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.0601 per EA (NDC 68462019005), effective Nov 18, 2026.

How has the price of NAPROXEN 500 MG TABLET changed over time?

Over the history we have for it, the NADAC for NAPROXEN 500 MG TABLET has risen 20.9%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for NAPROXEN 500 MG TABLET?

Since Nov 28, 2013, the NADAC for NAPROXEN 500 MG TABLET has ranged from a low of $0.0497 (Apr 17, 2024) to a high of $0.0874 (Aug 12, 2020), with a median of $0.0660 per EA.

Are there cheaper alternatives to NAPROXEN 500 MG TABLET?

Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NAPROXEN 500 MG TABLET, is $0.0580 per EA — about 3% below NAPROXEN 500 MG TABLET.

Who manufactures NAPROXEN 500 MG TABLET?

NAPROXEN 500 MG TABLET (NDC 68462019005) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.